Publications (24 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Biochemical, mechanical, and morphological properties of a completely autologous platelet-rich wound sealant
SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated …
- https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.654
- KH Toomer, GF Gerber, Y Zhang, L Daou, M Tushek… - …, 2023 - Wiley Online Library
- Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection results in coagulation activation although it is usually not associated with consumption coagulopathy. D‐…
Global Sources of Cryoprecipitate Demonstrate Variability in Coagulant Factor Quantity and Functional Hemostatic Equivalence.
Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart
Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models
Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma
Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury
Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy
High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality
Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study
Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study
Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure
Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue
* Evans B et al. (2019) Global Sources of Cryoprecipitate Demonstrate Variability in Coagulant Factor Quantity and Functional Hemostatic Equivalence.
* Gennadievna LY (2018) Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart. Tomsk National Research Medical Center of the Russian Academy of Sciences
* Engelmann B (2018) Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models. Ernst Moritz Arndt University of Greifswald. Dessertation.
* Johansson PI et al. (2013) Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 6(3):171-5
* Genet GF (2013) Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury. J Neurotrauma. 30:301?306
* Ostrowshi SR et al. (2012) Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J. Trauma Acute Care Surg. 73(1): 60-66.
* Johansson PI et al. (2012) High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 10(2):207-216
* Ostrowski SR et al. (2011) Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 19:64
* Johansson PI et al. (2011) Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Critical Care 15(6):R272
* Barua RS et al. (2010) Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure. Arterioscler Thromb Vasc Biol. 30(1):75-79
* Mohammed S et al. (2008) Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue. USPTO Patent Applicaton #: 20080267940
